CIK 0000727510 · Non-accelerated filer<br>Smaller reporting company
Viskase Holdings, Inc.
Sign in to watch- Ticker
- VISK
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 222372868
- Phone
- (630) 874-0700
- Business address
- 333 EAST BUTTERFIELD ROAD, SUITE 400, LOMBARD, IL, 60148
- Former names
- ENZON PHARMACEUTICALS, INC., ENZON PHARMACEUTICALS INC, ENZON PHARMACEUTICALS INC, ENZON PHARMACEUTICAL INC, ENZON INC
- 4 Open-market buy Interim PEO and Interim COO bought 5,000 shares at $6.88 ($34,395)
- 4 Open-market sale VP and General Counsel sold 1,614 shares at $6.81 ($10,983)
- 4 Open-market sale SVP, R&D Program Management sold 25,000 shares at $6.78 ($169,500)
- 4 Grant or award VP, Controller and PAO acquired 8,000 shares (grant or award)
- 4 Open-market sale Director sold 2,000 shares at $6.92 ($13,842)
- 4 Grant or award Director acquired 13,737 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 3/A Insider 3/A
- 4/A Derivatives Options or other derivatives
- 4 Grant or award VP, Clinical Development acquired 4,000 shares (grant or award)
- 4 Grant or award SVP, R&D Program Management acquired 10,000 shares (grant or award)
- 4 Grant or award VP and General Counsel acquired 10,000 shares (grant or award)
- 4 Grant or award VP, Research acquired 3,500 shares (grant or award)
- 4 Grant or award Executive VP, COO, PEO, CFO acquired 45,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 4 of 28 · 560 filings